Join
Live feed
·
PRReleasevia Quantisnow
Rocket Pharmaceuticals Inc. logo

Rocket Pharmaceuticals Provides Update on Phase 2 Clinical Trial of RP-A501 for Danon Disease

ByQuantisnow·Wall Street's wire, on your screen.
RCKT· Rocket Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RCKT (Rocket Pharmaceuticals Inc.) and more on Quantisnow.